Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1736 (LINC01736) is a long intergenic non-coding RNA (lincRNA), a class of RNA molecules that do not encode proteins but function primarily in the regulation of gene expression and epigenetic processes[3]. LINC01736, also known by aliases such as RP11-552D4.1, has been referenced in some molecular profiling and cancer biology contexts, but there is little to no direct experimental evidence specifically characterizing its function or disease role[2][4]. Like other lincRNAs, it may contribute to cellular regulatory networks, influence transcription or chromatin state, and could play context-dependent roles in disease, especially in cancer or immune-related processes; however, these functions have not been attributed to LINC01736 directly[1][3][5]. No known drugs, mechanisms of action, biomarker roles, or major safety concerns are currently associated with LINC01736.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1736 (LINC01736).